Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
Ho‐Young Yhim, T. Kim, Seung Ju Kim, Ho‐Jin Shin, Youngil Koh, Jin Sung Kim, Jinny Park, G.S. Park, Woo Seob Kim, Joon Ho Moon, Deok‐Hwan Yang
Topics & Concepts
MedicineGemcitabineNeutropeniaInternal medicinePhases of clinical researchGastroenterologyRefractory (planetary science)Adverse effectPeripheral T-cell lymphomaFebrile neutropeniaLymphomaOncologySurgeryChemotherapyImmunologyT cellImmune systemAstrobiologyPhysicsLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCutaneous lymphoproliferative disorders research